Effects of oxycodone pharmacogenetics on postoperative analgesia and related clinical outcomes in children: a pilot

Blessed W Aruldhas1,2,3, Sara K Quinney1,4,5, Senthil Packiasabapathy2

  • 1Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

Pharmacogenomics
|March 22, 2023
PubMed

Insights

Genetic variations in key genes influence how children process oxycodone, affecting their pain levels and recovery after surgery. This research identifies specific gene-outcome links for personalized pain management.

Area of Science:

  • Pharmacogenomics
  • Pediatric Surgery
  • Pain Management

Background:

  • Pharmacokinetic and pharmacodynamic variability of oxycodone in children is significant.
  • Genetic polymorphisms are potential contributors to this variability.
  • Understanding these genetic factors is crucial for optimizing pediatric pain management.

Purpose of the Study:

  • To investigate the association between specific pharmacogenes and clinical outcomes in pediatric surgical patients.
  • To explore the relationship between genetic variations and the effectiveness of oxycodone therapy.
  • To identify genetic markers that predict pain scores and recovery in children.

Main Methods:

  • A cohort of 89 children undergoing major surgery (pectus excavatum repair or spinal fusion) was studied.
  • Genotyping was performed for relevant pharmacogenes, including OPRM1, PXR, COMT, and ABCB1.
  • Clinical outcomes such as pain scores and length of hospital stay were recorded and analyzed.

Main Results:

  • OPRM1 SNP rs6902403 was significantly associated with maximum pain scores and total opioid dosage.
  • Other studied polymorphisms in OPRM1, PXR, COMT, and ABCB1 correlated with average opioid dosage, hospital stay duration, and maximum surgical pain.
  • P-values < 0.05 indicated statistically significant associations.

Conclusions:

  • This study reveals novel associations between specific pharmacogenes and oxycodone pharmacokinetics in children.
  • Identified gene-outcome relationships offer potential for tailoring oxycodone treatment and improving postoperative outcomes.
  • Findings support the role of pharmacogenetics in personalized pain management for pediatric surgical patients.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
363
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
313
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
699
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
175
Local Anesthetics: Pharmacokinetics01:13

Local Anesthetics: Pharmacokinetics

The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
822
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K